Research ExplorerPublicationsThe wearable cardioverter defibrillator as a bridge to reimp...

The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections

Standard

The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections. / Castro, L; Pecha, S; Linder, M; Vogler, J; Gosau, N; Meyer, C; Willems, S; Reichenspurner, H; Hakmi, S.

In: J CARDIOTHORAC SURG, Vol. 12, No. 1, 25.11.2017, p. 99.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Castro, L, Pecha, S, Linder, M, Vogler, J, Gosau, N, Meyer, C, Willems, S, Reichenspurner, H & Hakmi, S 2017, 'The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections', J CARDIOTHORAC SURG, vol. 12, no. 1, pp. 99. https://doi.org/10.1186/s13019-017-0669-2

APA

Castro, L., Pecha, S., Linder, M., Vogler, J., Gosau, N., Meyer, C., Willems, S., Reichenspurner, H., & Hakmi, S. (2017). The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections. J CARDIOTHORAC SURG, 12(1), 99. https://doi.org/10.1186/s13019-017-0669-2

Vancouver

Castro L, Pecha S, Linder M, Vogler J, Gosau N, Meyer C et al. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections. J CARDIOTHORAC SURG. 2017 Nov 25;12(1):99. https://doi.org/10.1186/s13019-017-0669-2

Bibtex

@article{a677da1cc516481d94c72969b6e36aec,
title = "The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections",
abstract = "BACKGROUND: The approach to treat device infection in patients with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) is a challenging procedure. Optimal treatment is complete extraction of the infected device. To protect these patients from sudden cardiac arrest while waiting for reimplantation and to avoid recurrent infection, a wearable cardioverter defibrillator (WCD) seems to be a valuable solution. Therefore, we investigated the management and outcome of patients with ICD or CRT-D infections using the WCD as a bridge to re-implantation after lead extraction procedures.METHODS: We conducted a retrospective study on consecutive patients who underwent ICD or CRT-D removal due to device-related local or systemic infections. All patients were prescribed a WCD at our center between 01/2012 and 10/2015. All patients returned to our outpatient clinic for regular ICD or CRT-D monitoring initially 1 and 3 months after reimplantation followed by 6-months intervals.RESULTS: Twenty-one patients (mean age 65.0 ± 8.0 years, male 76.2%) were included in the study. Complete lead extraction was achieved in all patients. While waiting for reimplantation one patient experienced a symptomatic episode of sustained ventricular tachycardia. This episode was converted successfully into sinus rhythm by a single 150 J shock. Mean follow-up time 392 ± 206 days, showing survival rate of 100% and freedom from reinfection in all patients.CONCLUSION: The WCD seems to be a valuable bridging option for patients with ICD or CRT-D infections, showing no recurrent device infection.",
keywords = "Aged, Anti-Bacterial Agents/therapeutic use, Death, Sudden, Cardiac/prevention & control, Defibrillators, Implantable, Device Removal, Electric Countershock/instrumentation, Electrocardiography, Female, Germany/epidemiology, Humans, Incidence, Male, Prosthesis-Related Infections/epidemiology, Replantation, Retrospective Studies, Survival Rate/trends, Tachycardia, Ventricular/physiopathology",
author = "L Castro and S Pecha and M Linder and J Vogler and N Gosau and C Meyer and S Willems and H Reichenspurner and S Hakmi",
year = "2017",
month = nov,
day = "25",
doi = "10.1186/s13019-017-0669-2",
language = "English",
volume = "12",
pages = "99",
journal = "J CARDIOTHORAC SURG",
issn = "1749-8090",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections

AU - Castro, L

AU - Pecha, S

AU - Linder, M

AU - Vogler, J

AU - Gosau, N

AU - Meyer, C

AU - Willems, S

AU - Reichenspurner, H

AU - Hakmi, S

PY - 2017/11/25

Y1 - 2017/11/25

N2 - BACKGROUND: The approach to treat device infection in patients with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) is a challenging procedure. Optimal treatment is complete extraction of the infected device. To protect these patients from sudden cardiac arrest while waiting for reimplantation and to avoid recurrent infection, a wearable cardioverter defibrillator (WCD) seems to be a valuable solution. Therefore, we investigated the management and outcome of patients with ICD or CRT-D infections using the WCD as a bridge to re-implantation after lead extraction procedures.METHODS: We conducted a retrospective study on consecutive patients who underwent ICD or CRT-D removal due to device-related local or systemic infections. All patients were prescribed a WCD at our center between 01/2012 and 10/2015. All patients returned to our outpatient clinic for regular ICD or CRT-D monitoring initially 1 and 3 months after reimplantation followed by 6-months intervals.RESULTS: Twenty-one patients (mean age 65.0 ± 8.0 years, male 76.2%) were included in the study. Complete lead extraction was achieved in all patients. While waiting for reimplantation one patient experienced a symptomatic episode of sustained ventricular tachycardia. This episode was converted successfully into sinus rhythm by a single 150 J shock. Mean follow-up time 392 ± 206 days, showing survival rate of 100% and freedom from reinfection in all patients.CONCLUSION: The WCD seems to be a valuable bridging option for patients with ICD or CRT-D infections, showing no recurrent device infection.

AB - BACKGROUND: The approach to treat device infection in patients with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) is a challenging procedure. Optimal treatment is complete extraction of the infected device. To protect these patients from sudden cardiac arrest while waiting for reimplantation and to avoid recurrent infection, a wearable cardioverter defibrillator (WCD) seems to be a valuable solution. Therefore, we investigated the management and outcome of patients with ICD or CRT-D infections using the WCD as a bridge to re-implantation after lead extraction procedures.METHODS: We conducted a retrospective study on consecutive patients who underwent ICD or CRT-D removal due to device-related local or systemic infections. All patients were prescribed a WCD at our center between 01/2012 and 10/2015. All patients returned to our outpatient clinic for regular ICD or CRT-D monitoring initially 1 and 3 months after reimplantation followed by 6-months intervals.RESULTS: Twenty-one patients (mean age 65.0 ± 8.0 years, male 76.2%) were included in the study. Complete lead extraction was achieved in all patients. While waiting for reimplantation one patient experienced a symptomatic episode of sustained ventricular tachycardia. This episode was converted successfully into sinus rhythm by a single 150 J shock. Mean follow-up time 392 ± 206 days, showing survival rate of 100% and freedom from reinfection in all patients.CONCLUSION: The WCD seems to be a valuable bridging option for patients with ICD or CRT-D infections, showing no recurrent device infection.

KW - Aged

KW - Anti-Bacterial Agents/therapeutic use

KW - Death, Sudden, Cardiac/prevention & control

KW - Defibrillators, Implantable

KW - Device Removal

KW - Electric Countershock/instrumentation

KW - Electrocardiography

KW - Female

KW - Germany/epidemiology

KW - Humans

KW - Incidence

KW - Male

KW - Prosthesis-Related Infections/epidemiology

KW - Replantation

KW - Retrospective Studies

KW - Survival Rate/trends

KW - Tachycardia, Ventricular/physiopathology

U2 - 10.1186/s13019-017-0669-2

DO - 10.1186/s13019-017-0669-2

M3 - SCORING: Journal article

C2 - 29178898

VL - 12

SP - 99

JO - J CARDIOTHORAC SURG

JF - J CARDIOTHORAC SURG

SN - 1749-8090

IS - 1

ER -